|
|
||||||||
Published online before print June 15, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Article |
@,
,
,
,
,
,
*CNRS, Laboratory of Therapeutic Immunology and Chemistry, IBMC, Strasbourg, France;
INSERM, Centre de Recherches Biomédicales des Cordeliers, Université Pierre et Marie Curie (Paris VI) et René Descartes (Paris V), Paris, France; and
Université Paris-Descartes, Faculté de Médecine, AP-HP, Hôtel-Dieu, Service d’Anatomie et de Cytologie Pathologiques, Paris, France
@ To whom correspondence should be addressed. E-mail: c.mueller{at}ibmc.u-strasbg.fr.
| Abstract |
|---|
Large B cell lymphomas can comprise numerous CD14+ cells in the tumor stroma, which raises the question of whether monocytes can support B cell survival and proliferation. We show that the coculture of monocytes with B cells from peripheral blood or from diffuse large B cell lymphoma enabled prolonged B cell survival. Under these conditions, diffuse large lymphoma B cells proliferated, and addition of B cell-activating factor of the TNF family and IL-2 enhanced cell division. Monocytes and dendritic cells (DC) had similar antiapoptotic activity on healthy B cells but displayed differences with respect to B cell proliferation. Monocytes and cord blood-derived CD14+ cells promoted B cell proliferation in the presence of an anti-CD40 stimulus, whereas DC supported B cell proliferation when activated through the BCR. DC and CD14+ cells were able to induce plasmocyte differentiation. When B cells were activated via the BCR or CD40, they released the leukocyte attractant CCL5, and this chemokine is one of the main chemokines expressed in diffuse large B cell lymphoma. The data support the notion that large B cell lymphoma recruit monocytes via CCL5 to support B cell survival and proliferation.
Key Words: macrophages chemokines tumor immunity
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH |